Genetic testing study for African Americans
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at genetic markers (genes) related to kidney risk in Black/African American adults. It may help researchers better understand who is at higher risk and how genetics could guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 90 years old
- Identify as Black or African American (including multi-racial with African ancestry)
- Be able to understand the study and give consent
- Not be terminally ill
- Not be on kidney machine treatments (hemodialysis/peritoneal dialysis or similar kidney replacement therapy)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows Native American adults with kidney function changes (either moderately reduced kidney filtration or early urine protein). It aims to better understand kidney disease over time and what factors predict progress, which may help improve care for people like you.
This study looks at health-related social needs—like barriers to food, housing, or care—in African American adults living with type 2 diabetes and chronic kidney disease. It uses a mixed-methods approach to understand needs better and what support may help.
This study looks at tiny genetic pieces in your blood to find markers that might help track kidney disease. If you join, researchers will compare these markers between healthy people, people with high blood pressure, and people with chronic kidney disease.
This trial uses genetic testing to find the cause of rare kidney diseases. It is for people with unexplained kidney problems, a family history of kidney disease, or certain findings on ultrasound. The goal is to provide a more personalized diagnosis and see if this approach is cost-effective.
This study checks if a new genetic test for the APOL1 gene works correctly. It uses samples from people who have already joined another drug trial.
This study looks at how genes affect kidney disease in people from diverse backgrounds. It may help researchers understand why some people get kidney disease and others don't, which could lead to better prevention and treatment.
Hear when a new Genetic Predisposition trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.